Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 2, 2002, Pages 345-351

  Lewis, R E ^a   Diekema, D J ^b   Messer, S A ^c   Pfaller, M A ^c   Klepser, M E ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b Division of Infectious Diseases

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG POTENTIATION; DRUG SCREENING; FUNGUS ISOLATION; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REPRODUCIBILITY;

EID: 0036178010     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.2.345     Document Type: Article

References (18)

1. Antimicrobial combinations
2. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
3. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans
4. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model
5. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: Effect of concentration and exposure time
6. Interactions in vitro between polyenes and imidazoles against yeasts
7. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates
8. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B
9. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media
10. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B-resistant Candida isolates
11. Multicentre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans
12. Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard, and E test
13. Etest for drug combination studies with mycobacteria
14. Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents
15. Instructions to authors
16. Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods
17. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections